Upon recommendation by underwriters’ counsel, members of CRA’s accounting and advisory team assisted a US-based bio-technology company in advance of its IPO by advising on existing compliance procedures, tightening financial controls, and enhancing internal reporting, governance, and risk management functions. CRA team members recommended and implemented both qualitative and systems-based solutions designed to address regulatory requirements.
Biden administration directs creation of sweeping new program to protect Americans’ sensitive personal data
On February 28, 2024, President Biden signed an executive order (EO), EO 14117, “Preventing Access to Americans’ Bulk Sensitive Personal Data and United States...